Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,955,306
+$1,403,449 QoQ
Shares Held
936,731
-1.1% QoQ
Ownership
0.636%
of shares outstanding
% of Portfolio
4.36%
of 13F equity value
Holder Rank
#28
of 149 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aldebaran Capital, LLC holds $7,545,514 across 6 Biotechnology names. ACRS ranks #1 (65.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
This page
|
936,731 | $4,955,306 | |
| 2 | TECX |
Tectonic Therapeutic, Inc.
|
36,797 | $1,265,080 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
467,432 | $626,358 | |
| 4 | AVIR |
Atea Pharmaceuticals, Inc.
|
88,180 | $410,037 | |
| 5 | OKUR |
OnKure Therapeutics, Inc.
|
39,869 | $181,802 | |
| 6 | IMA |
ImageneBio, Inc.
|
18,124 | $106,931 |
All Filings in ACRS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,955,306 | 936,731 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,551,857 | 947,162 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,872,328 | 954,262 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,876,626 | 987,698 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,411,051 | 993,698 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,542,175 | 1,007,958 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,522,055 | 1,016,958 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,199,624 | 1,043,152 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $943,967 | 858,152 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||